Alergologia

2021

1. Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy

   European Annals of Allergy and Clinical Immunology, Vol. 53, Núm. 2, pp. 67-74

2. Etoricoxib-induced fixed drug eruption: Report of seven cases

   Contact Dermatitis, Vol. 84, Núm. 3, pp. 192-195

3. Evidence of ige‐mediated cross‐reactions between anisakis simplex and contracaecum osculatum proteins

   Pathogens, Vol. 10, Núm. 8

4. Oral immunotherapy in severe cow’s milk allergic patients treated with omalizumab: Real life survey from a Spanish registry

   Pediatric Allergy and Immunology, Vol. 32, Núm. 6, pp. 1287-1295

5. Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

   BMC Pulmonary Medicine, Vol. 21, Núm. 1

6. Spanish society of allergology and clinical immunology (Seaic) vision of drug provocation tests

   Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 5, pp. 385-403

7. Tolerance to iopamidol in patients with confirmed allergic immediate hypersensitivity to iomeprol

   Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 5, pp. 2101-2103.e1